Advancing Non-Systemic Medicines for Inflammatory Skin Diseases Turn Therapeutics develops first-in-class topical cytokine-modulating therapeutics designed to deliver targeted anti-inflammatory effects without systemic immune exposure or injections. Explore GX-03 Explore Pipeline Turn Therapeutics is a clinical-stage biotechnology company advancing first-in-class targeted therapies designed to act where disease occurs, not where it does not. Our approach is […]